HC Wainwright & Co. Reiterates Buy on Mustang Bio, Maintains $25 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Mustang Bio (NASDAQ:MBIO) and maintained a $25 price target.
August 16, 2023 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mustang Bio's stock is likely to be positively impacted by the reiterated 'Buy' rating and maintained $25 price target from HC Wainwright & Co.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The reiterated 'Buy' rating and maintained $25 price target from HC Wainwright & Co. indicates their continued confidence in Mustang Bio, which could boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100